Nadya BradyFounder at LuminaBio AdvisorySpeaker
Profile
Nadya Brady is Founder and Managing Director of LuminaBio Advisory, where she advises life sciences companies on oligonucleotide CMC, regulatory strategy, analytical control strategy, and external development and manufacturing partnerships. With more than 20 years of experience across small and large pharma and biotech organizations, including GSK, GreenLight Bio, and Nitto Denko Avecia, she supports teams navigating development, operational readiness, and commercialization strategy for innovative therapies.
Agenda Sessions
Future-Proofing Oligonucleotide Manufacturing: Starting-Material Strategy for Scale-Up, Platform Change, and Commercial Supply Continuity
, 09:45View Session

